Verbal and Written Instruction Versus Verbal and Written Plus Simulation in Patients With Breast Cancer and Their Caregivers

NCT01829984 | Completed

• 1 other identifier: 13-057
• Study Type: observational
• Target: 51
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to compare two different ways of teaching people how to give injections at home. The first is what we do now, which is teaching patients and/or their caregivers verbally and by giving written instructions. The second is what we do now (verbal and written instructions) along with a demonstration and practice using a needle and an injection pad that feels similar to skin and fat. This is being done to find the best method for teaching people to give an injection at home.

Conditions

Breast Cancer

Keywords

Injection Teaching; 13-057

Outcome Measures

Primary Outcomes (1)

• compare verbal and written teaching for injection teaching

  with verbal and written teaching + simulation using an injection model, in terms of: * Patient/caregiver satisfaction * Patient/caregiver self-confidence * Nurse satisfaction

  1 year

Secondary Outcomes (3)

• Assess for changes in patient self-reported

  1 year

• Compare nurses' perceptions of patient/caregiver confidence levels

  1 year

• Compare the amount of nurses' time spent teaching

  1 year

Study Arms (2)

control injection teaching

The first 25 subjects recruited into the study will be that control group. Subjects accrued during the control phase will receive the control injection teaching, which at MSKCC is verbal instruction. To minimize practice variation, the teaching will be provided by the office-practice nurse guided by a verbal script. The consented subjects will complete a questionnaire before the teaching, immediately after the teaching, and after performing the injection the following day. The nurse who administered the teaching will also complete an evaluation immediately following the teaching.

Other: Verbal and Written Instruction

intervention group

The subsequent 25 subjects enrolled into the study will be in the intervention group. Subjects accrued during the intervention phase will receive the verbal and written injection teaching, plus demonstration and return demonstration using an injection model. It is anticipated that the intervention teaching will take no longer then 5 additional minutes, however time will be evaluated as a secondary objective as well in both groups. The consented subjects will complete a questionnaire before the teaching, immediately after the teaching, and after performing the injection the following day. The nurse who administered the teaching will also complete an evaluation immediately following the teaching.

Other: Verbal and Written Plus Simulation

Interventions

Verbal and Written Instruction OTHER

Pre-teaching Evaluation: Patient * Pre-teaching Evaluation: Caregiver o To be completed immediately before the teaching. Administered by the nurse who will provide the teaching. The form utilized will depend on if the patient or caregiver will be administering the injection. * Post-teaching Evaluation: Patient Post-teaching Evaluation: Caregiver To be completed immediately after the teaching. Administered by the nurse who provided the teaching. The form utilized will depend on if the patient or caregiver will be administering the injection.

control injection teaching

Verbal and Written Plus Simulation OTHER

Post-injection Evaluation: Patient * Post-injection Evaluation: Caregiver o To be completed after the injection is administered (outside of MSKCC) by the patient or caregiver. The form utilized will depend on if the patient or caregiver has administered the injection. They will return this evaluation at the patient's next visit (2 weeks later). * Nurse Evaluation: Control * Nurse Evaluation: Model o To be completed immediately following the completion of the teaching by the nurse. The form utilized will depend on if the teaching was part of the control or intervention phase of the study.

intervention group

Eligibility Criteria

• Age: 19 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All breast cancer medical oncology clinics at MSKCC will serve as recruitment clinics for the proposed study. Nurses will notify the PI of any patient due to start adjuvantadjuvant or neoadjuvant treatment when the regimen includes pegfilgrastim.

You may qualify if:

• English speaking
• Over 18 years of age
• No history of performing injections
• Patient must be receiving pegfilgrastim during adjuvant or neoadjuvant chemotherapy
• Patient will have the pegfilgrastim administered at home either by self administering or by a caregiver.

You may not qualify if:

• Patient or caregiver desire to inject (with saline) during or immediately following the injection teaching
• Prior self-injection or injection administration experience of any type
• Patients with history of anaphylaxis or other severe reactions to latex
• Patients that required pegfilgrastim injection be administered in clinic

Sponsors & Collaborators

• Memorial Sloan Kettering Cancer Center: lead

Study Sites (1)

Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States

Location

Related Links

• Memorial Sloan-Kettering Cancer Center

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Study Officials

• Erica Fischer-Cartlidge, RN, MSN

  Memorial Sloan Kettering Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 9, 2013
• First Posted: April 11, 2013
• Study Start: April 1, 2013
• Primary Completion: September 1, 2015
• Study Completion: September 1, 2015
• Last Updated: September 4, 2015

Record last verified: 2015-09

Locations

US (1)